Catalyst overview
Research summary
This catalyst tracks a Phase 1/2 data readout for CR-001 in Solid tumor/s. The expected timing is based on the latest available company guidance and may change.
07/30/26:- ASCEND PoC Q1 2027; chemo and sac-TMT combo data Mid-2027; sac-TMT Ph2 underway.
Verification
Confirm timing and program details against the company announcement or filing.